Development of CD163 targeting agent for imaging and therapy
— T-020196 CD163 Targeting Agent for Imaging and Therapy
Technology Description
Researchers in Yongjian Liu’s laboratory at Washington University have synthesized a new peptide-based CD163 radiotracer. CD163 is a well-known biomarker specific to macrophages implicated in multiple diseases, but…